Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

PCOS and Brain Health

19. august 2026 opdateret af: University of Wisconsin, Madison

Functional and Structural Impacts of Polycystic Ovary Syndrome (PCOS) on Brain Health

The purpose of this study is to determine how polycystic ovary syndrome (PCOS) impacts overall brain health, such as cerebral blood flow (CBF), brain structure and connectivity, and cognitive performance. 45 reproductive aged (18-45 years) individuals with ovaries, with and without PCOS, will be enrolled to complete brain structure and CBF scans via magnetic resonance imaging (MRI) over 2 testing visits and can expect to be on study for approximately 5 hours over a 1 to 3 month period.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Aim 1: To determine whether individuals with PCOS exhibit reduced CBF at global, lobe and regional brain levels.

Aim 2: To assess whether individuals with PCOS have alterations in brain structure including grey and white volume, cortical thickness, or connectivity compared to controls.

Aim 3: To evaluate whether individuals with PCOS demonstrate impairments in cognitive performance, including verbal fluency, memory, and processing speed, relative to controls.

Aim 4: To characterize systemic immune cell states, circulating inflammatory and metabolic profiles, and epigenomic regulatory landscapes in peripheral blood of individuals with and without PCOS, and to evaluate whether these multiomic signatures are associated with CBF, brain structure, connectivity, and cognitive performance.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

45

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

  • Forenede Stater
    • Wisconsin
      • Madison, Wisconsin, Forenede Stater, 53792
        • Rekruttering
        • University of Wisconsin

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ja

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

Reproductive-aged individuals with ovaries, with and without PCOS

Beskrivelse

Inclusion Criteria (Participants with PCOS):

  • Rotterdam criteria demonstrating two out of the three criteria. These are:

    1. Presence of clinical hyperandrogenism or biochemical hyperandrogenism
    2. A history of irregular menstrual cycles
    3. Presence of polycystic ovarian morphology on ultrasound

Inclusion Criteria (Healthy Controls):

  • Regular menstrual cycles (not meeting criteria for irregular cycles above)
  • No diagnosis of PCOS
  • Controls may have isolated hirsutism or polycystic ovaries on ultrasound as long as they do not meet Rotterdam criteria for PCOS

Exclusion Criteria:

  • Current pregnancy
  • Preexisting diagnosis of type 1 diabetes
  • Severe obesity (body mass index (BMI) greater than 45kg/m2)
  • Preexisting diagnosis of hypertension requiring antihypertensive medication or blood pressure of greater than 160/100 on two separate occasions during clinical care
  • History of neurologic disease or stroke
  • History of myocardial infarction or deep venous thrombosis
  • Endometriosis confirmed by prior laparoscopy
  • Autoimmune conditions including lupus, multiple sclerosis, and active malignancy
  • Immuno-modulating medications

  • Conditions incompatible with MRI scanning, including but not limited to

    • Certain implanted metal devices or foreign bodies
    • Severe claustrophobia
  • Post-menopausal
  • Participants will be excluded if they have taken hormonal contraception or fertility medication in the last month

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Participants with PCOS
N=30 participants recruited
Enhed: MRI Visit
MRI visit will take approximately 1.5 hour (55-60 minutes in MRI) and will involve structural scans of the brain, and scans at rest and while performing cognitive tasks.
Andre navne:
  • MR scanning
Andet: Laboratory Visit
DEXA scan for obtaining body composition, NIH toolbox to assess cognitive test, and optional graded exercise test (GXT).
Healthy Controls
N=15 age and BMI-matched participants recruited
Enhed: MRI Visit
MRI visit will take approximately 1.5 hour (55-60 minutes in MRI) and will involve structural scans of the brain, and scans at rest and while performing cognitive tasks.
Andre navne:
  • MR scanning
Andet: Laboratory Visit
DEXA scan for obtaining body composition, NIH toolbox to assess cognitive test, and optional graded exercise test (GXT).

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cerebral Blood Flow (CBF) at rest
Tidsramme: data collected during a 2-hour MRI visit (anytime up to 3 months on study)
Arterial Spin Labeling (ASL) color atlases and 4D Flow MRI will be used to measure CBF at rest. CBF will be measured in each of six brain regions: temporal, parietal, frontal, occipital, subcortical, and brainstem.
data collected during a 2-hour MRI visit (anytime up to 3 months on study)
Circulating Sex Hormone Levels
Tidsramme: data collected during a 2-hour MRI visit (anytime up to 3 months on study)
data collected during a 2-hour MRI visit (anytime up to 3 months on study)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Body composition via DEXA scan
Tidsramme: data collected during a 2-hour lab visit (anytime up to 3 months on study)
Percent body fat and lean mass to be measured via Dual-Energy X-ray Absorptiometry (DEXA) scan.
data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox: Dimensional Change Card Sort Test
Tidsramme: data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox to assess neurocognitive function. The Dimensional Change Card Sort Test measures accuracy: the number of accurate responses, up to a maximum of 40.
data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox: Pattern Comparison Processing Speed Test
Tidsramme: data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox to assess neurocognitive function. The Pattern Comparison Processing Speed Test measures how many correct responses the participant has within 90 seconds. There is a maximum of 130 items.
data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox: Flanker Inhibitory Control and Attention
Tidsramme: data collected during a 2-hour lab visit (anytime up to 3 months on study)
NIH Toolbox to assess neurocognitive function. The Flanker test is a measure of executive function and is scored using a T-score where 100 is the average, higher scores indicate better performance.
data collected during a 2-hour lab visit (anytime up to 3 months on study)
Cardiorespiratory fitness (VO2max) [Optional]
Tidsramme: data collected during a 2-hour lab visit (anytime up to 3 months on study)
data collected during a 2-hour lab visit (anytime up to 3 months on study)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

University of Wisconsin, Madison

Efterforskere

  • Ledende efterforsker: Laura Cooney, MD, University of Wisconsin, Madison

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

7. august 2026

Primær færdiggørelse (Anslået)

1. august 2028

Studieafslutning (Anslået)

1. august 2028

Datoer for studieregistrering

Først indsendt

21. juli 2026

Først indsendt, der opfyldte QC-kriterier

21. juli 2026

Først opslået (Faktiske)

27. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

21. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 2026-0690
  • Protocol Version 6/29/2026 (Anden identifikator: UW Madison)
  • SMPH / Reproductive Endo (REI) (Anden identifikator: UW Madison)
  • ICTR Pilot Award (Andet bevillings-/finansieringsnummer: NCATS)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner